NCT07491822 2026-03-24A Single-Arm, Single-Center, Phase II Clinical Study of Camrelizumab Combined With Radiochemotherapy as Neoadjuvant Therapy for Early-Stage Triple-Negative Breast CancerTianjin Medical University Cancer Institute and HospitalPhase NA Not yet recruiting43 enrolled